Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer

por Bharti, Rashmi, Dey, Goutam, Das, Anjan Kumar, Mandal, Mahitosh
Publicado 2018

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)

por Rosenberg, Jonathan E., Hahn, Noah M., Regan, Meredith M., Werner, Lillian, Alva, Ajjai, George, Saby, Picus, Joel, Alter, Robert, Balar, Arjun, Hoffman-Censits, Jean, Grivas, Petros, Lauer, Richard, Guancial, Elizabeth A., Hoimes, Christopher, Sonpavde, Guru, Albany, Constantine, Stein, Mark N., Breen, Tim, Jacobs, Cindy, Anderson, Kirsten, Bellmunt, Joaquim, Lalani, Aly-Khan A., Pal, Sumanta, Choueiri, Toni K.
Publicado 2018

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinom...

por Abou Faycal, Cherine, Brambilla, Elisabeth, Agorreta, Jackeline, Lepeltier, Nina, Jacquet, Thibault, Lemaître, Nicolas, Emadali, Anouk, Lucas, Anthony, Lacal, Pedro M, Montuenga, Luis, Pio, Ruben, Gazzeri, Sylvie, Eymin, Beatrice
Publicado 2018

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

por Thomsen, Maria, Skovlund, Eva, Sorbye, Halfdan, Bolstad, Nils, Nustad, Kjell Johannes, Glimelius, Bengt, Pfeiffer, Per, Kure, Elin H., Johansen, Julia S., Tveit, Kjell Magne, Christoffersen, Thoralf, Guren, Tormod Kyrre
Publicado 2018

Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial

por Shi, Tingyan, Jiang, Rong, Yu, Jinjin, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Shen, Yang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
Publicado 2018

The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores

por Dolan, Ross D, McSorley, Stephen T, Park, James H, Watt, David G, Roxburgh, Campbell S, Horgan, Paul G, McMillan, Donald C
Publicado 2018

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

por Zunder, Stéphanie M., van Pelt, Gabi W., Gelderblom, Hans J., Mancao, Christoph, Putter, Hein, Tollenaar, Rob A., Mesker, Wilma E.
Publicado 2018

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

por Derks-Smeets, Inge A. P., Schrijver, Lieske H., de Die-Smulders, Christine E. M., Tjan-Heijnen, Vivianne C. G., van Golde, Ron J. T., Smits, Luc J., Caanen, Beppy, van Asperen, Christi J., Ausems, Margreet, Collée, Margriet, van Engelen, Klaartje, Kets, C. Marleen, van der Kolk, Lizet, Oosterwijk, Jan C., van Os, Theo A. M., Rookus, Matti A., van Leeuwen, Flora E., Gómez García, Encarna B.
Publicado 2018

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

por Ruscito, Ilary, Cacsire Castillo-Tong, Dan, Vergote, Ignace, Ignat, Iulia, Stanske, Mandy, Vanderstichele, Adriaan, Glajzer, Jacek, Kulbe, Hagen, Trillsch, Fabian, Mustea, Alexander, Kreuzinger, Caroline, Benedetti Panici, Pierluigi, Gourley, Charlie, Gabra, Hani, Nuti, Marianna, Taube, Eliane T., Kessler, Mirjana, Sehouli, Jalid, Darb-Esfahani, Silvia, Braicu, Elena Ioana
Publicado 2018

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation st...

por Munster, Pamela, Krop, Ian E., LoRusso, Patricia, Ma, Cynthia, Siegel, Barry A., Shields, Anthony F., Molnár, István, Wickham, Thomas J., Reynolds, Joseph, Campbell, Karen, Hendriks, Bart S., Adiwijaya, Bambang S., Geretti, Elena, Moyo, Victor, Miller, Kathy D.
Publicado 2018

A randomised controlled trial of an advance care planning intervention for patients with incurable cancer

por Johnson, Stephanie B., Butow, Phyllis N., Bell, Melanie L., Detering, Karen, Clayton, Josephine M., Silvester, William, Kiely, Belinda E., Clarke, Stephen, Vaccaro, Lisa, Stockler, Martin R., Beale, Phillip, Fitzgerald, Natalie, Tattersall, Martin H. N.
Publicado 2018

Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer

por Heim, Lisanne, Kachler, Katerina, Siegmund, Raphaela, Trufa, Denis I., Mittler, Susanne, Geppert, Carol-Immanuel, Friedrich, Juliane, Rieker, Ralf J., Sirbu, Horia, Finotto, Susetta
Publicado 2019

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study

por Kim, Jin Won, Lee, Kyung-Hun, Kim, Ji-Won, Suh, Koung Jin, Nam, Ah-Rong, Bang, Ju-Hee, Bang, Yung-Jue, Oh, Do-Youn
Publicado 2019

Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours

por Yoo, Changhoon, Ryu, Yeon-mi, Kim, Sang-Yeob, Kim, Jihun, Ock, Chan Young, Ryu, Min-Hee, Kang, Yoon-Koo
Publicado 2019

TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis

por Zhang, Guanghui, Zhu, Qingzong, Fu, Gang, Hou, Jianbing, Hu, Xiaosong, Cao, Jiangjun, Peng, Wen, Wang, Xiaowen, Chen, Fei, Cui, Hongjuan
Publicado 2019

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)

por Sim, Sung Hoon, Park, In Hae, Jung, Kyung Hae, Kim, Sung-Bae, Ahn, Jin-Hee, Lee, Kyung-Hun, Im, Seock-Ah, Im, Young-Hyuck, Park, Yeon Hee, Sohn, Joohyuk, Kim, Yu Jung, Lee, Suee, Kim, Hee-Jun, Chae, Yee Soo, Park, Kyong Hwa, Nam, Byung-Ho, Lee, Keun Seok, Ro, Jungsil
Publicado 2019

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

por Nassar, Amin H., Mouw, Kent W., Jegede, Opeyemi, Shinagare, Atul B., Kim, Jaegil, Liu, Chia-Jen, Pomerantz, Mark, Harshman, Lauren C., Van Allen, Eliezer M., Wei, Xiao X., McGregor, Bradley, Choudhury, Atish D., Preston, Mark A., Dong, Fei, Signoretti, Sabina, Lindeman, Neal I., Bellmunt, Joaquim, Choueiri, Toni K., Sonpavde, Guru, Kwiatkowski, David J.
Publicado 2019

Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial

por Belkouz, Ali, de Vos-Geelen, Judith, Mathôt, Ron A. A., Eskens, Ferry A. L. M., van Gulik, Thomas M., van Oijen, Martijn G. H., Punt, Cornelis J. A., Wilmink, Johanna W., Klümpen, Heinz-Josef
Publicado 2020

Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study

por Okada, Norio, Iwama, Shintaro, Okuji, Takayuki, Kobayashi, Tomoko, Yasuda, Yoshinori, Wada, Eri, Onoue, Takeshi, Goto, Motomitsu, Sugiyama, Mariko, Tsunekawa, Taku, Takagi, Hiroshi, Hagiwara, Daisuke, Ito, Yoshihiro, Suga, Hidetaka, Banno, Ryoichi, Hase, Tetsunari, Morise, Masahiro, Kanda, Mitsuro, Yokota, Kenji, Hashimoto, Naozumi, Ando, Masahiko, Fujimoto, Yasushi, Nagino, Masato, Kodera, Yasuhiro, Fujishiro, Mitsuhiro, Hibi, Hideharu, Sone, Michihiko, Kiyoi, Hitoshi, Gotoh, Momokazu, Ando, Yuichi, Akiyama, Masashi, Hasegawa, Yoshinori, Arima, Hiroshi
Publicado 2020

Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study

por Hosen, Md Ismail, Sheikh, Mahdi, Zvereva, Maria, Scelo, Ghislaine, Forey, Nathalie, Durand, Geoffroy, Voegele, Catherine, Poustchi, Hossein, Khoshnia, Masoud, Roshandel, Gholamreza, Sotoudeh, Masoud, Nikmanesh, Arash, Etemadi, Arash, Avogbe, Patrice Hodonou, Chopard, Priscilia, Delhomme, Tiffany Myriam, Foll, Matthieu, Manel, Arnaud, Vian, Emmanuel, Weiderpass, Elisabete, Kamangar, Farin, Boffetta, Paolo, Pharaoh, Paul D., Dawsey, Sanford M., Abnet, Christian C., Brennan, Paul, McKay, James, Malekzadeh, Reza, Calvez-Kelm, Florence Le
Publicado 2020